Terminated PHASE2 INTERVENTIONAL 2-arm
NCT03733119
ONC201 With a Methionine-Restricted Diet in Patients With Metastatic Triple Negative Breast Cancer
Sponsor: The V Foundation for Cancer Research
Conditions
Triple Negative Breast Cancer
Interventions
Akt/ERK Inhibitor ONC201 Methionine-Restricted Diet
Updated 1 time since 2024 Last updated: Feb 11, 2022 Started: Nov 13, 2018 Primary completion: Feb 13, 2021 Completion: Feb 13, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Terminated
Slow accrual
Other Triple Negative Breast Cancer trials with similar outcome
This PHASE2 trial investigates Triple Negative Breast Cancer and is currently terminated or withdrawn. The V Foundation for Cancer Research leads this study, which shows 1 recorded version since 2018 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
1 version recorded Terminated — PHASE2
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- The V Foundation for Cancer Research
- University of Wisconsin, Madison
Data source: University of Wisconsin, Madison
For direct contact, visit the study record on ClinicalTrials.gov .